Health Condition 1: K263- Acute duodenal ulcer without hemorrhage or perforation Health Condition 2: K20-K31- Diseases of esophagus, stomach and duodenum
Conditions
Interventions
Intervention1: nebulised dexmedetomidine in esophagogastroduodenoscopy: dexmedetomidine 1�µg/kg diluted in normal saline (0.9%) to make a volume of 5 ml nebulised to patients undergoing esophagogasr
Sponsors
IMS and SUM Hospital
Eligibility
Inclusion criteria
Inclusion criteria: ASA-1, 2, age 18 years to 65 years Elective esophagogastroduodenoscopy
Exclusion criteria
Exclusion criteria: a therapeutic EGD, ASA- Class 3 or higher, uncontrolled hypertension, seizure disorders, patient on anti-depressants/anti-psychotics, patients with a poor cardiopulmonary reserve and with body mass index (BMI) >30 kg/m2, renal failure, decompensated cirrhosis, age less than 18 years or more than 65 years, being pregnant, or refusal to provide written informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome was the patientââ?¬â?¢s self-reported discomfort scores during esophageal intubation, assessed with a 0ââ?¬â??10 (0 - none; 10 - unbearable) visual analog scale. Timepoint: Baseline, and after 10 minutes | — |
Secondary
| Measure | Time frame |
|---|---|
| discomfort score during the procedure and overall satisfaction with the procedure (0 - not satisfied at all; 10 - very satisfied) as evaluated by the patients; patient tolerance to the procedure, ease of intubation of the endoscope, and satisfaction with the procedure as evaluated by the endoscopists; and number of coughing and retching episodesTimepoint: time is during the procedure till completion of esophagogastroduodenoscopy | — |
Countries
India
Contacts
Public ContactDr Bhavna Sriramka
IMS and sum hospital
Outcome results
None listed